Conditions: Head and Neck Squamous Cell Carcinoma; Margin Assessment
Intervention: Drug: Cetuximab-IRDye800CW
Sponsors: University Medical Center Groningen; UMC Utrecht; Erasmus Medical Center, Rotterdam
Not yet recruiting - verified April 2017
http://ift.tt/2pOLCQI
http://ift.tt/2poa5KW
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
Expanding Perspectives in Airway Stenosis. JAMA Otolaryngol Head Neck Surg. 2017 Feb 23;: Authors: Daniero JJ PMID: 28241172 [PubMed...
-
Publication date: December 2016 Source: Archives of Oral Biology, Volume 72 Author(s): Rizky Aditiya Irwandi, Anjalee Vacharaksa MicroRN...
-
Universal health coverage – Time to dismantle vertical public health programs in India Raman Kumar Journal of Family Medicine and Primary Ca...
-
Influenza virus infection exacerbates experimental autoimmune encephalomyelitis disease by promoting type I T cells infiltration into cen...
-
Sampling the Body Odor of Primates: Cotton Swabs Sample Semivolatiles Rather Than Volatiles. Chem Senses. 2016 Apr 27; Authors: Birke...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου